| Source | Match | ReputationScore* | 
|---|---|---|
                NICAM: Nilotinib treatment for c-KIT mutated advanced AMM
                
                   Collection of samples and data across the following diseases: Malignant melanoma of eye (disorder). Phase II single arm study evaluating the activity of nilotinib in rare c-KIT mutated acral and mucosal melanoma (AMM). Entry into the trial is a 2 ste
                   ...
                
                 
             | 
            
                
                     | 
        
*ReputationScore indicates how established a given datasource is. Find out more.